United States Chagas Disease Drug Market Report 2017

Publisher Name :
Date: 02-Jan-2018
No. of pages: 110
Inquire Before Buying

In this report, the United States Chagas Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

- The West

- Southwest

- The Middle Atlantic

- New England

- The South

- The Midwest

with sales (volume), revenue (value), market share and growth rate of Chagas Disease Drug in these regions, from 2012 to 2022 (forecast).

United States Chagas Disease Drug market competition by top manufacturers/players, with Chagas Disease Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

- AstraZeneca Plc

- Bayer AG

- Daiichi Sankyo Co Ltd

- Eisai Co Ltd

- GlaxoSmithKline Plc

- Grupo Praxis Pharmaceutical SA

- Humanigen Inc

- Kancera AB

- Merck & Co Inc

- Novartis AG

- Oblita Therapeutics BVBA

- Sanofi

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Cz-007

- Cz-008

- D-121

- DNDI-0690

- EPLBS-1246

- EPLBS-967

- Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Hospital

- Clinic

- Others

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Chagas Disease Drug Market Report 2017

Table of Contents
United States Chagas Disease Drug Market Report 2017
1 Chagas Disease Drug Overview
1.1 Product Overview and Scope of Chagas Disease Drug
1.2 Classification of Chagas Disease Drug by Product Category
1.2.1 United States Chagas Disease Drug Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Chagas Disease Drug Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Cz-007
1.2.4 Cz-008
1.2.5 D-121
1.2.6 DNDI-0690
1.2.7 EPLBS-1246
1.2.8 EPLBS-967
1.2.9 Others
1.3 United States Chagas Disease Drug Market by Application/End Users
1.3.1 United States Chagas Disease Drug Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 United States Chagas Disease Drug Market by Region
1.4.1 United States Chagas Disease Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Chagas Disease Drug Status and Prospect (2012-2022)
1.4.3 Southwest Chagas Disease Drug Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Chagas Disease Drug Status and Prospect (2012-2022)
1.4.5 New England Chagas Disease Drug Status and Prospect (2012-2022)
1.4.6 The South Chagas Disease Drug Status and Prospect (2012-2022)
1.4.7 The Midwest Chagas Disease Drug Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Chagas Disease Drug (2012-2022)
1.5.1 United States Chagas Disease Drug Sales and Growth Rate (2012-2022)
1.5.2 United States Chagas Disease Drug Revenue and Growth Rate (2012-2022)
2 United States Chagas Disease Drug Market Competition by Players/Suppliers
2.1 United States Chagas Disease Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Chagas Disease Drug Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Chagas Disease Drug Average Price by Players/Suppliers (2012-2017)
2.4 United States Chagas Disease Drug Market Competitive Situation and Trends
2.4.1 United States Chagas Disease Drug Market Concentration Rate
2.4.2 United States Chagas Disease Drug Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Chagas Disease Drug Manufacturing Base Distribution, Sales Area, Product Type
3 United States Chagas Disease Drug Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Chagas Disease Drug Sales and Market Share by Region (2012-2017)
3.2 United States Chagas Disease Drug Revenue and Market Share by Region (2012-2017)
3.3 United States Chagas Disease Drug Price by Region (2012-2017)
4 United States Chagas Disease Drug Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Chagas Disease Drug Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Chagas Disease Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Chagas Disease Drug Price by Type (2012-2017)
4.4 United States Chagas Disease Drug Sales Growth Rate by Type (2012-2017)
5 United States Chagas Disease Drug Sales (Volume) by Application (2012-2017)
5.1 United States Chagas Disease Drug Sales and Market Share by Application (2012-2017)
5.2 United States Chagas Disease Drug Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Chagas Disease Drug Players/Suppliers Profiles and Sales Data
6.1 AstraZeneca Plc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Chagas Disease Drug Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AstraZeneca Plc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Bayer AG
6.2.2 Chagas Disease Drug Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Bayer AG Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Daiichi Sankyo Co Ltd
6.3.2 Chagas Disease Drug Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Daiichi Sankyo Co Ltd Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Eisai Co Ltd
6.4.2 Chagas Disease Drug Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Eisai Co Ltd Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline Plc
6.5.2 Chagas Disease Drug Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GlaxoSmithKline Plc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Grupo Praxis Pharmaceutical SA
6.6.2 Chagas Disease Drug Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Humanigen Inc
6.7.2 Chagas Disease Drug Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Humanigen Inc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Kancera AB
6.8.2 Chagas Disease Drug Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Kancera AB Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck & Co Inc
6.9.2 Chagas Disease Drug Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck & Co Inc Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis AG
6.10.2 Chagas Disease Drug Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis AG Chagas Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Oblita Therapeutics BVBA
6.12 Sanofi
7 Chagas Disease Drug Manufacturing Cost Analysis
7.1 Chagas Disease Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chagas Disease Drug
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Chagas Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Chagas Disease Drug Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Chagas Disease Drug Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Chagas Disease Drug Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Chagas Disease Drug Sales Volume Forecast by Type (2017-2022)
11.3 United States Chagas Disease Drug Sales Volume Forecast by Application (2017-2022)
11.4 United States Chagas Disease Drug Sales Volume Forecast by Region (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Chagas Disease Drug
Figure United States Chagas Disease Drug Market Size (K Pcs) by Type (2012-2022)
Figure United States Chagas Disease Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Cz-007 Product Picture
Figure Cz-008 Product Picture
Figure D-121 Product Picture
Figure DNDI-0690 Product Picture
Figure EPLBS-1246 Product Picture
Figure EPLBS-967 Product Picture
Figure Others Product Picture
Figure United States Chagas Disease Drug Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Chagas Disease Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Chagas Disease Drug Market Size (Million USD) by Region (2012-2022)
Figure The West Chagas Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Chagas Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Chagas Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Chagas Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Chagas Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Chagas Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Chagas Disease Drug Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Chagas Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Chagas Disease Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Chagas Disease Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Chagas Disease Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Chagas Disease Drug Sales Share by Players/Suppliers
Figure 2017 United States Chagas Disease Drug Sales Share by Players/Suppliers
Figure United States Chagas Disease Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Chagas Disease Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Chagas Disease Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Chagas Disease Drug Revenue Share by Players/Suppliers
Figure 2017 United States Chagas Disease Drug Revenue Share by Players/Suppliers
Table United States Market Chagas Disease Drug Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Chagas Disease Drug Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Chagas Disease Drug Market Share of Top 3 Players/Suppliers
Figure United States Chagas Disease Drug Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Chagas Disease Drug Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Chagas Disease Drug Product Category
Table United States Chagas Disease Drug Sales (K Pcs) by Region (2012-2017)
Table United States Chagas Disease Drug Sales Share by Region (2012-2017)
Figure United States Chagas Disease Drug Sales Share by Region (2012-2017)
Figure United States Chagas Disease Drug Sales Market Share by Region in 2016
Table United States Chagas Disease Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Chagas Disease Drug Revenue Share by Region (2012-2017)
Figure United States Chagas Disease Drug Revenue Market Share by Region (2012-2017)
Figure United States Chagas Disease Drug Revenue Market Share by Region in 2016
Table United States Chagas Disease Drug Price (USD/Pcs) by Region (2012-2017)
Table United States Chagas Disease Drug Sales (K Pcs) by Type (2012-2017)
Table United States Chagas Disease Drug Sales Share by Type (2012-2017)
Figure United States Chagas Disease Drug Sales Share by Type (2012-2017)
Figure United States Chagas Disease Drug Sales Market Share by Type in 2016
Table United States Chagas Disease Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Chagas Disease Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Chagas Disease Drug by Type (2012-2017)
Figure Revenue Market Share of Chagas Disease Drug by Type in 2016
Table United States Chagas Disease Drug Price (USD/Pcs) by Types (2012-2017)
Figure United States Chagas Disease Drug Sales Growth Rate by Type (2012-2017)
Table United States Chagas Disease Drug Sales (K Pcs) by Application (2012-2017)
Table United States Chagas Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Chagas Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Chagas Disease Drug Sales Market Share by Application in 2016
Table United States Chagas Disease Drug Sales Growth Rate by Application (2012-2017)
Figure United States Chagas Disease Drug Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Plc Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer AG Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure Bayer AG Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure Bayer AG Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Daiichi Sankyo Co Ltd Basic Information List
Table Daiichi Sankyo Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Daiichi Sankyo Co Ltd Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure Daiichi Sankyo Co Ltd Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure Daiichi Sankyo Co Ltd Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Eisai Co Ltd Basic Information List
Table Eisai Co Ltd Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eisai Co Ltd Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure Eisai Co Ltd Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure Eisai Co Ltd Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Grupo Praxis Pharmaceutical SA Basic Information List
Table Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure Grupo Praxis Pharmaceutical SA Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure Grupo Praxis Pharmaceutical SA Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Humanigen Inc Basic Information List
Table Humanigen Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Humanigen Inc Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure Humanigen Inc Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure Humanigen Inc Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Kancera AB Basic Information List
Table Kancera AB Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kancera AB Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure Kancera AB Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure Kancera AB Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Merck & Co Inc Basic Information List
Table Merck & Co Inc Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co Inc Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure Merck & Co Inc Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure Merck & Co Inc Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Chagas Disease Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Chagas Disease Drug Sales Growth Rate (2012-2017)
Figure Novartis AG Chagas Disease Drug Sales Market Share in United States (2012-2017)
Figure Novartis AG Chagas Disease Drug Revenue Market Share in United States (2012-2017)
Table Oblita Therapeutics BVBA Basic Information List
Table Sanofi Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chagas Disease Drug
Figure Manufacturing Process Analysis of Chagas Disease Drug
Figure Chagas Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Chagas Disease Drug Major Players/Suppliers in 2016
Table Major Buyers of Chagas Disease Drug
Table Distributors/Traders List
Figure United States Chagas Disease Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Chagas Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Chagas Disease Drug Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Chagas Disease Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Chagas Disease Drug Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Chagas Disease Drug Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Chagas Disease Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Chagas Disease Drug Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Chagas Disease Drug Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Chagas Disease Drug Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Chagas Disease Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Chagas Disease Drug Sales Volume Share Forecast by Region (2017-2022)
Figure United States Chagas Disease Drug Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Liquid Chromatography Detectors Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 109
    Liquid Chromatography Detectors is a device used in liquid chromatography (LC) to detect components of the mixture being eluted off the chromatography column. A broad range of detectors is available to meet different sample requirements. Specific detectors respond to a particular compound only and the response is independent of mobile phase composition. On the other hand the response of bulk property detectors is dependent on collective changes in composition of sample and mobile phase. ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Scope of the Report: This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in Global market, especially in North America,......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Fractional Flow Reserve Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Fractional flow reserve (FFR) is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis (narrowing, usually due to atherosclerosis) to determine the likelihood that the stenosis impedes oxygen delivery to the heart muscle (myocardial ischemia). Scope of the Report: This report focuses on the Fractional Flow Reserve in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle Eas......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) IV Bags Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 103
    This report studies the IV Bag market including flex plastics bag, semi-rigid IV Bags, glass bottles. Scope of the Report: This report focuses on the IV Bags in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers - Baxter - SSY Group - ......
  • North America and Europe Casting and Splinting Products Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    An orthopedic cast, or simply cast, is a shell, frequently made from plaster or fiberglass, encasing a limb (or, in some cases, large portions of the body) to stabilize and hold anatomical structures, most often a broken bone (or bones), in place until healing is confirmed. It is similar in function to a splint. Scope of the Report: This report focuses on the Casting and Splinting Products in North America and Europe market, especially in United States, United Kingd......
  • North America and Europe Breast Lesion Localization Methods Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 109
    This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products. Scope of the Report: This report focuses on the Breast Lesion Localization Methods in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application......
  • North America and Europe APAC Silver Dressing Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 103
    Silver dressings are a relatively new family of advanced wound care dressings for the treatment of infected wounds. A silver dressing is a wound dressing impregnated with ionic silver. The ionic silver is responsible for the anti-microbial activity against infection caused by bacteria. Scope of the Report: This report focuses on the APAC Silver Dressing in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy an......
  • North America and Europe APAC Hydrocolloid Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    A hydrocolloid dressing is an opaque or transparent dressing for wounds. A hydrocolloid dressing is biodegradeable, non-breathable, and adheres to the skin, so no separate taping is needed. Scope of the Report: This report focuses on the APAC Hydrocolloid in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and appl......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Orally Disintegrating Tablet Market 2018 Forecast to 2023
    Published: 27-Apr-2018        Price: US 4880 Onwards        Pages: 102
    An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs